Figure 4.1

Cardiovascular disease in patients with or without chronic kidney disease, 2009
[Download]

Figure 4.2

Geographic variations in rates (per 1,000 population) of congestive heart failure (CHF) in patients with CKD, by HSA
[Download]

Figure 4.3

Patients with CHF who receive diagnostic testing, by CKD status
[Download]

Figure 4.4

Geographic variations in rates (per 1,000 population) of CVA/TIA in CKD patients, by HSA
[Download]

Figure 4.5

i Patients hospitalized for CVA/TIA who receive diagnostic testing, by CKD status
[Download]

Figure 4.6

Geographic variations in the percent of patients with CHF who receive medication for their condition, by CKD status & state, 2008
[Download]

Figure 4.7

Prescription drug therapy in patients with CHF, by CKD status & race, 2008
[Download]

Figure 4.8

i Prescription drug therapy in patients with AMI, by CKD status & race, 2008
[Download]

Figure 4.9

Prescription drug therapy in patients with atrial fibrillation, by CKD status & race, 2008
[Download]

Figure 4.10

Prescription drug therapy in patients with CVA/TIA, by CKD status & race, 2008
[Download]

Figure 4.11

Percent of patients treated for CHF, by type of medication & CKD status, 2008
[Download]

Table A

Cardiovascular disease & intervention (percent), by CKD status & diagnosis code, 2009
[Download]

Table B

Cardiovascular disease & pharmacological intervention (percent), by CKD status & diagnosis code, 2008
[Download]